Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hui-qi Wu"'
Autor:
Hui-Qi Wu, Peng-Peng Kuang, Wei Ou, Jian Li, Ning Li, Tian-Yu Sun, Si-Yu Wang, Ming-Tian Li, Yang Shao, Bao-Xiao Wang, Jian-Jun Li, Zui Liu
Publikováno v:
Cancer. 128:708-718
Circulating tumor DNA (ctDNA) has emerged as a noninvasive biomarker for dynamically monitoring tumors. However, published data on perioperative ctDNA in patients with operable non-small cell lung cancer (NSCLC) are currently limited.This prospective
Autor:
Wen-guo Ye, Hai-hua Yao, You-jiang Min, Kai-tao Luo, Jie Sun, Zheng Yuan, Hui-qi Wu, Li-hong Cheng
Background: The syndrome of kidney-yang deficiency is one of the main syndromes in traditional Chinese medicine. Modern evidences prove that the hypothalamus - pituitary - adrenal axis (HPA axis) function disorder is the main material basis of kidney
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b67cbaffd86a875ef1c582bff0d091
https://doi.org/10.21203/rs.3.rs-86968/v1
https://doi.org/10.21203/rs.3.rs-86968/v1
Publikováno v:
Clinical Neurology and Neurosurgery. 160:96-100
Objective Brain metastases remain lethal in lung cancer patients. The impacts of epidermal growth factor receptor (EGFR) mutations and EGFR tyrosine kinase inhibitors (TKIs) on the incidence of brain metastases in patients with advanced non-squamous
Publikováno v:
Journal of Clinical Oncology. 38:9023-9023
9023 Background: Circulating tumor DNA can be detected in the plasma and serum of patients with solid tumors and has emerged as a noninvasive biomarker for dynamically monitoring tumor. Postsurgical ctDNA analysis of early-stage NSCLC may identify pa
Publikováno v:
Journal of Clinical Oncology. 35:e20626-e20626
e20626 Background: Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), has been proved to be effective and safe in treating patients with advanced gastric cancer who failed to second-line chemotherapy. As